These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 39536859)
1. Long non-coding RNA AC105118.1 affects glycolysis to facilitate oxaliplatin resistance in colorectal cancer cells by modulating the miR-378a-3p/KIF26B axis. Zhang Y; Shen Z; Han X; Wu Y; Huang T Int J Biochem Cell Biol; 2024 Dec; 177():106692. PubMed ID: 39536859 [TBL] [Abstract][Full Text] [Related]
2. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
3. The miR-1269a/PCDHGA9/CXCR4/β-catenin pathway promotes colorectal cancer invasion and metastasis. Mei H; Luo Q; Weng J; Hao J; Cai J; Zhou R; Bian C; Ye Y; Luo S; Wen Y Cell Mol Biol Lett; 2024 Nov; 29(1):144. PubMed ID: 39587482 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
5. EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5p. Yi J; Ye Z; Xu H; Zhang H; Cao H; Li X; Wang T; Dong C; Du Y; Dong S; Zhou W Phytomedicine; 2024 Dec; 135():156137. PubMed ID: 39566403 [TBL] [Abstract][Full Text] [Related]
6. Casticin suppresses self-renewal related stemness via miR-342-3p-mediated FoxM1 downregulation in cervical cancer cells. Cao X; Hu X; Xu X; Zhu W; Lin Q; Le Y; Feng W; Xu Y; Lin S Phytomedicine; 2024 Dec; 135():156036. PubMed ID: 39277988 [TBL] [Abstract][Full Text] [Related]
7. Sishen pills inhibit inflammatory dendritic cell differentiation via miR-505-3p mediated E-cadherin downregulation in ulcerative colitis. Huang J; Zhong Y; Cheng N; Zhang Z; Huang L; Song L; Cheng S; Zhao H; Liu D Phytomedicine; 2024 Dec; 135():156035. PubMed ID: 39342779 [TBL] [Abstract][Full Text] [Related]
8. [GINS1 Enhances Glycolysis, Proliferation and Metastasis in Lung Adenocarcinoma Cells by Activating the Notch/PI3K/AKT/mTORC1 Signaling Pathway]. Huo Y; Xu X; Ma X; Feng Y Zhongguo Fei Ai Za Zhi; 2024 Oct; 27(10):735-744. PubMed ID: 39631830 [TBL] [Abstract][Full Text] [Related]
9. SULT2B1: a novel therapeutic target in colorectal cancer via modulation of AKT/PKM2-mediated glycolysis and proliferation. Ma J; Sun F; Li W; Du R; Liu M; Wei Q; Kang B; Yan S; Wang C J Transl Med; 2024 Dec; 22(1):1093. PubMed ID: 39623433 [TBL] [Abstract][Full Text] [Related]
10. [Mechanism of Tongfu Lifei decoction inhibiting the programmed death-1/programmed death-ligand 1 signaling pathway in THP-1 cells by regulating microRNA-146a]. Lyu B; Li L; Huang R; Zhou X; Han L Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Oct; 36(10):1038-1043. PubMed ID: 39586721 [TBL] [Abstract][Full Text] [Related]
11. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
12. Cepharanthine sensitizes gastric cancer cells to chemotherapy by targeting TRIB3-FOXO3-FOXM1 axis to inhibit autophagy. Lu YY; Fang YY; Wang SS; Guo J; Song JL; Zhu L; Lin ZK; Wang R; Zhang SY; Qiu WS; Qi WW Phytomedicine; 2024 Dec; 135():156161. PubMed ID: 39454374 [TBL] [Abstract][Full Text] [Related]
13. Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial. Kim P; Sanchez AM; Penke TJR; Tuson HH; Kime JC; McKee RW; Slone WL; Conley NR; McMillan LJ; Prybol CJ; Garofolo PM Lancet Infect Dis; 2024 Dec; 24(12):1319-1332. PubMed ID: 39134085 [TBL] [Abstract][Full Text] [Related]
14. Metformin Inhibits the Progression of Pancreatic Cancer Through Regulating miR-378a-3p/VEGFA/RGC-32 Axis. He J; Luo Y; Ding Y; Zhu L Cancer Med; 2024 Dec; 13(23):e70446. PubMed ID: 39606802 [TBL] [Abstract][Full Text] [Related]
16. BVES-AS1 suppresses the colorectal cancer progression via the miR-1269a/b-SVEP1-PI3K/AKT axis. Yang J; Deng Q; Chen Z; Chen Y; Fu Z Adv Clin Exp Med; 2024 Nov; 33(11):1217-1236. PubMed ID: 38239081 [TBL] [Abstract][Full Text] [Related]
17. Euphorbia Pekinensis Rupr. sensitizes colorectal cancer to PD-1 blockade by remodeling the tumor microenvironment and enhancing peripheral immunity. Chen YY; Zeng XT; Gong ZC; Zhang MM; Wang KQ; Tang YP; Huang ZH Phytomedicine; 2024 Dec; 135():156107. PubMed ID: 39368338 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I. Stephenson ZA; Harvey RF; Pryde KR; Mistry S; Hardy RE; Serreli R; Chung I; Allen TE; Stoneley M; MacFarlane M; Fischer PM; Hirst J; Kellam B; Willis AE Elife; 2020 May; 9():. PubMed ID: 32432547 [TBL] [Abstract][Full Text] [Related]
19. Using Experience Sampling Methodology to Capture Disclosure Opportunities for Autistic Adults. Love AMA; Edwards C; Cai RY; Gibbs V Autism Adulthood; 2023 Dec; 5(4):389-400. PubMed ID: 38116059 [TBL] [Abstract][Full Text] [Related]